Following a new breakthrough medical direction Mozaik launches the corporate website of RTsafe exploiting the benefits of a highly specialized innovation aiming to diminish medical risk during radiation oncology treatments.

The medical technology company, RTsafe, envisioned a safe radiologic environment that would minimize the radiation risk and ensure patient safety. Drawing from years of expertise and research on the matter, the company succeeded in formulating a tailored to patient pre-treatment head effigy, a perfect replica of the patient’s bones, skin and tissue, composed of specialized material that radiation oncologists, medical physicists and radiation therapists could treat as if the real patient, before proceeding with the actual treatment.

RTsafe’s patient-specific dosimetry phantoms (PSDPs) and the personalized QA data analysis provided have paved the way for more precise treatment interventions reducing risk to the patient.

This breakthrough idea was one of the winners of the Hellenic Entrepreneurship Award of 2014.  With the funds awarded from HEA and the valuable support of the Libra Group RTsafe continued its immense journey towards medical revolution with its participation in many universal forums and conferences as well as its international cooperation with leading medical institutions throughout the globe, from Americas to Northern Europe.

For more information visit the new website of RTsafe supported by Mozaik http://www.rt-safe.com/ and spread the word.